EPISODE · Mar 28, 2022 · 30 MIN
Una cátedra para la inmunoterapia
from Biotecnología Capital · host Capital Radio
José Cabrera, director médico de Bristol Myers Squibb para España y Portugal, nos explica qué objetivos tiene esta cátedra. Explica qué son las terapias de células T con CAR y cómo pueden ayudar a la supervivencia de los pacientes con cánceres de sangre.
Embed this episode
NOW PLAYING
Una cátedra para la inmunoterapia
0:00
30:55
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotecnología Capital?
This episode is 30 minutes long.
When was this Biotecnología Capital episode published?
This episode was published on March 28, 2022.
Can I download this Biotecnología Capital episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!